ENABLE 2017, the First European PhD and Post-Doc Symposium. Session 1: Building the Foundations of Biology: Synthetic and Cellular Research
Research output: Contribution to journal › Conference article › Research › peer-review
Standard
ENABLE 2017, the First European PhD and Post-Doc Symposium. Session 1 : Building the Foundations of Biology: Synthetic and Cellular Research. / Di Mauro, Gianmarco; Dondi, Ambra; Giangreco, Giovanni; Hogrebe, Alexander; Louer, Elja; Magistrati, Elisa; Mullari, Meeli; Turon, Gemma; Verdurmen, Wouter; Xicoy Cortada, Helena; Zivanovic, Sanja.
In: Biomolecules, Vol. 8, No. 3, 46, 2018, p. 1-6.Research output: Contribution to journal › Conference article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - GEN
T1 - ENABLE 2017, the First European PhD and Post-Doc Symposium. Session 1
T2 - ENABLE 2017
AU - Di Mauro, Gianmarco
AU - Dondi, Ambra
AU - Giangreco, Giovanni
AU - Hogrebe, Alexander
AU - Louer, Elja
AU - Magistrati, Elisa
AU - Mullari, Meeli
AU - Turon, Gemma
AU - Verdurmen, Wouter
AU - Xicoy Cortada, Helena
AU - Zivanovic, Sanja
N1 - Conference code: 1
PY - 2018
Y1 - 2018
N2 - The European Academy for Biomedical Science (ENABLE) is an initiative funded by the European Union Horizon 2020 program involving four renowned European Research Institutes (Institute for Research in Biomedicine—IRB Barcelona, Spain; Radboud Institute for Molecular Life Sciences—RIMLS, the Netherlands; Novo Nordisk Foundation Center for Protein Research—NNF CPR, Denmark; European School of Molecular Medicine—SEMM, Italy) and an innovative science communication agency (Scienseed). With the aim of promoting biomedical science of excellence in Europe, ENABLE organizes an annual three-day international event. This gathering includes a top-level scientific symposium bringing together leading scientists, PhD students, and post-doctoral fellows; career development activities supporting the progression of young researchers and fostering discussion about opportunities beyond the bench; and outreach activities stimulating the interaction between science and society. The first European PhD and Postdoc Symposium, entitled “Breaking Down Complexity: Innovative Models and Techniques in Biomedicine”, was hosted by the vibrant city of Barcelona. The scientific program of the conference was focused on the most recent advances and applications of modern techniques and models in biomedical research and covered a wide range of topics, from synthetic biology to translational medicine. Overall, the event was a great success, with more than 200 attendees from all over Europe actively participating in the symposium by presenting their research and exchanging ideas with their peers and world-renowned scientists.
AB - The European Academy for Biomedical Science (ENABLE) is an initiative funded by the European Union Horizon 2020 program involving four renowned European Research Institutes (Institute for Research in Biomedicine—IRB Barcelona, Spain; Radboud Institute for Molecular Life Sciences—RIMLS, the Netherlands; Novo Nordisk Foundation Center for Protein Research—NNF CPR, Denmark; European School of Molecular Medicine—SEMM, Italy) and an innovative science communication agency (Scienseed). With the aim of promoting biomedical science of excellence in Europe, ENABLE organizes an annual three-day international event. This gathering includes a top-level scientific symposium bringing together leading scientists, PhD students, and post-doctoral fellows; career development activities supporting the progression of young researchers and fostering discussion about opportunities beyond the bench; and outreach activities stimulating the interaction between science and society. The first European PhD and Postdoc Symposium, entitled “Breaking Down Complexity: Innovative Models and Techniques in Biomedicine”, was hosted by the vibrant city of Barcelona. The scientific program of the conference was focused on the most recent advances and applications of modern techniques and models in biomedical research and covered a wide range of topics, from synthetic biology to translational medicine. Overall, the event was a great success, with more than 200 attendees from all over Europe actively participating in the symposium by presenting their research and exchanging ideas with their peers and world-renowned scientists.
KW - Biomedicine
KW - Cancer
KW - Morphogenesis
KW - Protocells
KW - Stem cells
KW - Super resolution microscopy
KW - Symposium
KW - Synthetic biology
KW - stem cells
KW - biomedicine
KW - super resolution microscopy
KW - symposium
KW - synthetic biology
KW - morphogenesis
KW - protocells
KW - cancer
U2 - 10.3390/biom8030046
DO - 10.3390/biom8030046
M3 - Conference article
C2 - 29986405
VL - 8
SP - 1
EP - 6
JO - Biomolecules
JF - Biomolecules
SN - 2218-273X
IS - 3
M1 - 46
Y2 - 15 November 2017 through 17 November 2017
ER -
ID: 200288219